The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and Outcomes

被引:0
作者
Du, Amy T. [1 ,3 ]
Pang, Jonathan C. [1 ]
Victor, Robert [1 ]
Meller, Leo Li Tang [1 ]
Torabi, Sina J. [1 ]
Goshtasbi, Khodayar [1 ]
Kim, Michael G. [2 ]
Hsu, Frank P. K. [2 ]
Kuan, Edward C. [1 ]
机构
[1] Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Orange, CA 92697 USA
[2] Univ Calif Irvine, Dept Neurol Surg, Orange, CA USA
[3] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL USA
关键词
Chordoma; Hospital volume; Outcomes; Overall survival; Skull base chordoma;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
-OBJECTIVE: To evaluate the influence of facility case volume and type on skull base chordoma treatment and overall survival (OS). -METHODS: The 2004-2016 National Cancer Database was queried for skull base chordoma patients receiving definitive treatment. Facilities were categorized into 2 cohorts by calculating the mean number of patients treated per facility and using cutoff numbers that were 0.5 SD above and below the computed mean to separate the groups. As, by definition of the inclusion criteria, all included facilities treated at least 1 patient, low-volume facilities were defined as treating 1 patient, and high -volume facilities were defined as treating double dagger 7 patients; mid-volume facilities (facilities treating double dagger 2 but 6 pound patients) were excluded. Differences in treatment course, outcomes, and OS by facility type were assessed.-RESULTS: The study included 658 patients (44.8% female, 79.5% White). The 187 unique facilities were categorized into 95 low-volume facilities (treating 1 patient during timeline) and 26 high-volume facilities (treating double dagger 7 patients during timeline). Kaplan-Meier log-rank analysis demon-strated a significant positive association between facility volume and OS (P < 0.001) and an improvement in OS in patients at academic facilities (P = 0.018). On Cox pro-portional hazards multivariate regression after adjusting for sex, age, Charlson-Deyo comorbidity index, and insur-ance type, high-volume facilities and academic facilities were associated with a lower mortality risk than low -volume facilities and nonacademic facilities (P < 0.001 and P = 0.03, respectively).-CONCLUSIONS: Higher facility case volume and aca-demic facility type appear to be associated with improved survival outcomes in treatment of skull base chordomas.
引用
收藏
页码:e561 / e567
页数:7
相关论文
共 50 条
  • [1] The Influence of Facility Volume and Type on Skull Base Chordoma Treatment and Outcomes
    Du, Amy T.
    Pang, Jonathan C.
    Victor, Robert
    Meller, Leo Li Tang
    Torabi, Sina J.
    Goshtasbi, Khodayar
    Kim, Michael G.
    Hsu, Frank P. K.
    Kuan, Edward C.
    WORLD NEUROSURGERY, 2022, 166 : E561 - E567
  • [2] Influence of facility volume and type on esthesioneuroblastoma treatment and outcomes
    Goshtasbi, Khodayar
    Vasudev, Milind
    Torabi, Sina J.
    Roman, Kelsey
    Abiri, Arash
    Lehrich, Brandon M.
    Hsu, Frank P. K.
    Kuan, Edward C.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (08) : 1056 - 1059
  • [3] Impact of Type of Treatment Center and Access to Care on Mortality and Survival for Skull Base Chordoma and Chondrosarcoma
    Holtzman, Adam L.
    Bates, James E.
    Morris, Christopher G.
    Rutenberg, Michael S.
    Indelicato, Daniel J.
    Tavanaiepour, Daryoush
    Mendenhall, William M.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2022, 83 (03) : 328 - 338
  • [4] Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma
    Jacob L. Freeman
    Franco DeMonte
    Wajd Al-Holou
    Paul W. Gidley
    Ehab Y. Hanna
    Michael E. Kupferman
    Shirley Y. Su
    Shaan M. Raza
    Acta Neurochirurgica, 2018, 160 : 731 - 740
  • [5] Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study
    Masaru Takagi
    Yusuke Demizu
    Fumiko Nagano
    Kazuki Terashima
    Osamu Fujii
    Dongcun Jin
    Masayuki Mima
    Yasue Niwa
    Kuniaki Katsui
    Masaki Suga
    Tomohiro Yamashita
    Takashi Akagi
    Koh-ichi Sakata
    Nobukazu Fuwa
    Tomoaki Okimoto
    Radiation Oncology, 13
  • [6] Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma
    Freeman, Jacob L.
    DeMonte, Franco
    Al-Holou, Wajd
    Gidley, Paul W.
    Hanna, Ehab Y.
    Kupferman, Michael E.
    Su, Shirley Y.
    Raza, Shaan M.
    ACTA NEUROCHIRURGICA, 2018, 160 (04) : 731 - 740
  • [7] Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study
    Takagi, Masaru
    Demizu, Yusuke
    Nagano, Fumiko
    Terashima, Kazuki
    Fujii, Osamu
    Jin, Dongcun
    Mima, Masayuki
    Niwa, Yasue
    Katsui, Kuniaki
    Suga, Masaki
    Yamashita, Tomohiro
    Akagi, Takashi
    Sakata, Koh-ichi
    Fuwa, Nobukazu
    Okimoto, Tomoaki
    RADIATION ONCOLOGY, 2018, 13
  • [8] Expression of Cathepsin K in Skull Base Chordoma
    Tian, Kaibing
    Ma, Junpeng
    Wang, Liang
    Wang, Ke
    Li, Da
    Hao, Shuyu
    Yang, Yang
    Du, Jiang
    Jia, Guijun
    Zhang, Liwei
    Wu, Zhen
    Zhang, Junting
    WORLD NEUROSURGERY, 2017, 101 : 396 - 404
  • [9] Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis
    Muhonen, Ethan G.
    Yasaka, Tyler M.
    Lehrich, Brandon M.
    Goshtasbi, Khodayar
    Papagiannopoulos, Peter
    Tajudeen, Bobby A.
    St John, Maie A.
    Harris, Jeremy P.
    Hsu, Frank P. K.
    Kuan, Edward C. C.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2023, 84 (01) : 60 - 68
  • [10] Hemorrhagic Skull Base Chordoma Presenting As Chordoma Apoplexy
    Uysal, Ece
    Cohen, Michael A.
    Abou-Al-Shaar, Hussam
    Palmer, Cheryl
    Couldwell, William
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)